AlliancePharma Announces Appointment of New Director, Dr. Sami B. Chaouch


THETFORD MINES, QUEBEC--(Marketwired - June 18, 2015) - AlliancePharma Inc. (TSX VENTURE:APA) ("AlliancePharma" or "The Company") is pleased to announce that Dr. Sami B. Chaouch has been appointed to the Company's Board of Directors. Dr. Chaouch holds a PhD. in Finance from the University Paris-Dauphine and a business administration degree from HEC Carthage in Tunisia. He worked at many high profile international jobs in finance and corporate advisory services, with a special focus on media, tourism industry, before being appointed as Chief financial officer and member of the Board of Directors of V Media Group in Montreal.

"We are very honored and proud to have Dr. Chaouch as a director on our Board of director. He will bring strong expertise and knowledge in financing and management to the Board of the Company. He will also provide a strong and solid support to the management team of AlliancePharma to become a key player in the health services industry in Quebec and the rest of Canada", commented Marc Lemieux, Chairman of the Board of AlliancePharma.

AlliancePharma also announces that Mr. Maxime Lemieux has resigned as a director of the Company to be able to focus his attention on the Company's legal needs. The Board thanks Mr. Lemieux for his service as director to the Company.

The appointment is subject to the TSX Venture Exchange approval.

About AlliancePharma

AlliancePharma is a leader in the recruitment and placement of pharmacists and technical assistants in Quebec. The Acquisition of Élitis Pharma forms part of the vision of the management team of the Company to expand and diversify its activities, which led to its public listing in January, 2015. Additional information regarding the Company is available at www.alliancepharma.ca and on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its regulatory services provider (as defined in the policies of the TSX Venture Exchange) are in any way liable for the relevance of the present release.

Contact Information:

Yann Langlais-Plante
TACT Intelligence-conseil
(514) 779-2874
ylanglais-plante@tactconseil.ca